Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr245 Inhibitors

Olr245 inhibitors represent a class of chemical compounds specifically designed to target and inhibit the function of the Olr245 protein, which is a member of the larger olfactory receptor family. Olfactory receptors are G protein-coupled receptors (GPCRs) primarily responsible for the detection of odorant molecules, and they play a significant role in the sensory perception of smell. The Olr245 protein, like other olfactory receptors, is embedded in the cell membrane, where it interacts with various ligands that bind to it, triggering a cascade of intracellular signaling events. The inhibition of Olr245 by specific inhibitors involves the binding of these chemical compounds to the receptor in such a way that it prevents the activation of downstream signaling pathways. This interaction often involves a high degree of specificity, as the inhibitor must effectively compete with endogenous ligands for binding to the receptor's active site.

The development of Olr245 inhibitors requires a deep understanding of the receptor's structure, including its binding pocket and the conformational changes it undergoes upon ligand binding. Structural studies, often involving techniques such as X-ray crystallography or cryo-electron microscopy, provide insights into how these inhibitors interact with the receptor at a molecular level. The design of these inhibitors typically involves structure-activity relationship (SAR) studies, where chemical modifications are made to a lead compound to enhance its binding affinity, selectivity, and stability. Additionally, computational methods, such as molecular docking and dynamic simulations, are employed to predict the binding modes and optimize the interactions between the inhibitor and Olr245. The research into Olr245 inhibitors is part of a broader effort to understand the nuanced mechanisms of olfactory signaling and how specific receptors contribute to complex biological processes beyond olfaction.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Amiloride

2609-46-3sc-337527
1 g
$296.00
7
(1)

Sodium channel blocker, can modulate ion transport, potentially impacting Olr245.

Clotrimazole

23593-75-1sc-3583
sc-3583A
100 mg
1 g
$42.00
$57.00
6
(2)

Antifungal agent, might affect fungal cell membrane function, impacting Olr245 indirectly.

Diltiazem

42399-41-7sc-204726
sc-204726A
1 g
5 g
$209.00
$464.00
4
(1)

Calcium channel blocker, could alter calcium signaling, potentially impacting Olr245.

Furosemide

54-31-9sc-203961
50 mg
$41.00
(1)

Loop diuretic, can influence fluid balance and electrolyte transport, potentially impacting Olr245.

Hydralazine-15N4 Hydrochloride

304-20-1 (unlabeled)sc-490605
1 mg
$480.00
(0)

Vasodilator, could affect vascular smooth muscle function, impacting Olr245.

Indomethacin

53-86-1sc-200503
sc-200503A
1 g
5 g
$29.00
$38.00
18
(1)

NSAID, may modulate prostaglandin synthesis pathways, affecting Olr245.

Nifedipine

21829-25-4sc-3589
sc-3589A
1 g
5 g
$59.00
$173.00
15
(1)

Calcium channel blocker, might influence calcium-dependent signaling, impacting Olr245.

Omeprazole

73590-58-6sc-202265
50 mg
$67.00
4
(1)

Proton pump inhibitor, could alter gastric acid secretion pathways, impacting Olr245.

Verapamil

52-53-9sc-507373
1 g
$374.00
(0)

Calcium channel blocker, may modulate intracellular calcium signaling, affecting Olr245.